Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/PA/Reading

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Reading, PA

Studies commonly pay $75 to $4,500 per completed study

269 clinical trials are currently recruiting participants within 30 miles of Reading. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

269studies recruiting

2+research centers nearby

5condition categories

Live from the NIH registry

Studies recruiting near Reading right now

Top 25 of 269 recruiting studies, sorted by proximity — each links to its official registry page

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Acute Leukemia, Newly Diagnosed N/A Observational 1,365 participants sought

Lehigh Valley Health Network — Allentown, Pennsylvania (29.5 mi) · Sponsor: Memorial Sloan Kettering Cancer Center

See eligibility & contact on ClinicalTrials.gov (NCT02677064)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought

Penn State Health Saint Joseph Medical Center — Reading, Pennsylvania (0.3 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought

Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT03937635)

RA-PRO PRAGMATIC TRIAL

Rheumatoid Arthritis Phase 3 Interventional 924 participants sought

PA Regional Center for Arthritis and Osteoporosis Research — Wyomissing, Pennsylvania (2.2 mi) · Sponsor: University of Alabama at Birmingham

See eligibility & contact on ClinicalTrials.gov (NCT04692493)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought

Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Foundational Programs to Combat Clinician Stress

Burnout, Professional, Stress, Psychological N/A Interventional 180 participants sought

Penn Medicine Lancaster General Health — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Lancaster General Hospital

See eligibility & contact on ClinicalTrials.gov (NCT07220421)

Comparing Direct vs Indirect Methods for Cascade Screening

Long QT Syndrome, Familial Hypercholesterolemia N/A Interventional 200 participants sought

University of Maryland Amish Research Clinic — Lancaster, Pennsylvania (28.9 mi) · Sponsor: University of Maryland, Baltimore

See eligibility & contact on ClinicalTrials.gov (NCT05348564)

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves' Disease Phase 2 Interventional 240 participants sought

Site Number - 1043 — Pottstown, Pennsylvania (16.0 mi) · Sponsor: Immunovant Sciences GmbH

See eligibility & contact on ClinicalTrials.gov (NCT06727604)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought

Cardiology Associates of West Reading — West Reading, Pennsylvania (1.2 mi) · Sponsor: Duke University

See eligibility & contact on ClinicalTrials.gov (NCT06909565)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought

Lancaster General Hospital — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Bristol-Myers Squibb

See eligibility & contact on ClinicalTrials.gov (NCT07361510)

C-Brace Prospective Registry

Pareses, Lower Extremity N/A Observational 250 participants sought

Ability x Ottobock.care — Wyomissing, Pennsylvania (2.2 mi) · Sponsor: Otto Bock Healthcare Products GmbH

See eligibility & contact on ClinicalTrials.gov (NCT04640584)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Phase 2 Interventional 146 participants sought

Lancaster General Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05673148)

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought

Ephrata Cancer Center — Ephrata, Pennsylvania (17.3 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06532279)

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Colorectal Cancer Phase 2 Interventional 120 participants sought

UPenn Lancaster-Ann B. Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Criterium, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06992258)

WellSpan-THRIVE Cancer QOL Study

Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative, Cancer (Solid Tumors) N/A Observational 1,000 participants sought

WellSpan Ephrata Cancer Center — Ephrata, Pennsylvania (17.3 mi) · Sponsor: WellSpan Health

See eligibility & contact on ClinicalTrials.gov (NCT07433660)

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 335 participants sought

Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05554406)

Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention

Suicide and Depression, Adolescent Behavior N/A Interventional 900 participants sought

Berks Community Health Center — Reading, Pennsylvania (0.3 mi) · Sponsor: University of Pittsburgh

See eligibility & contact on ClinicalTrials.gov (NCT05748730)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought

Penn State Health Saint Joseph Medical Center — Reading, Pennsylvania (0.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought

Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05879926)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic Arthritis Phase 3 Interventional 1,088 participants sought

PA Regional Center for Arthritis and Osteoporosis Research — Wyomissing, Pennsylvania (2.2 mi) · Sponsor: Takeda

See eligibility & contact on ClinicalTrials.gov (NCT06671483)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought

Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (29.5 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2, Phase 3 Interventional 131 participants sought

Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04628767)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought

Reading Hospital — West Reading, Pennsylvania (1.2 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT06118281)

Pan-tumor MRD Study

Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer N/A Observational 1,350 participants sought

Lancaster General Hospital (UPenn) — Lancaster, Pennsylvania (28.9 mi) · Sponsor: Paradigm Health

See eligibility & contact on ClinicalTrials.gov (NCT06605404)

Use of tAN® in Alcohol Withdrawal Management

Alcohol Withdrawal N/A Interventional 60 participants sought

Caron Treatment Centers — Wernersville, Pennsylvania (8.1 mi) · Sponsor: Erin Deneke

See eligibility & contact on ClinicalTrials.gov (NCT06771037)

Actively enrolling

Studies you may be able to join near Reading

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Reading

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Research Center-Reading

2760 Century Blvd #3, Reading, PA 19610

(610) 375-2466

Lehigh Center for Clinical Research

★ 5.0

1245 S Cedar Crest Blvd, Allentown, PA 18103

(610) 820-0342

Website

"Staff was very friendly and explained information to me in great detail"

— Virgilio Baello, 5★

Clinical trials in Reading: what's recruiting

The Reading area currently has 269 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Reading, the most active research areas are:

Cancer & Oncology15 studies
Immune & Skin2 studies
Heart & Vascular2 studies
Brain & Mental Health1 studies
Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Reading, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Reading

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Reading participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Reading pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Reading?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Reading safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Reading, PA?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

What is the difference between a research center and a hospital study in Reading?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Reading

Other metros within reach

Lancaster, PA426 Allentown, PA230 Philadelphia, PA2,174 York, PA446 Harrisburg, PA403 Scranton, PA92 Trenton, NJ2,342 Baltimore, MD1,657

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Reading Chronic Kidney Disease (HealthMatch) in Reading Bladder Issues Due To Spinal Cord Injury in Reading All conditions

More of PA

Philadelphia2,174 Pittsburgh1,243 York446 Lancaster426 Harrisburg403 Allentown230 Scranton92 Erie89

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts